title: Circulating immunoreactive proANP(1-30) and proANP(31-67) in sedentary subjects and athletes.
abstract: BACKGROUND
  Atrial natriuretic peptide (ANP) is synthesized and stored in myocytes as prohormone(1-126), which upon release is cleaved into proANP(1-98) and alpha-ANP(99-126). In addition, cleavage of proANP(1-98) produces proANP(1-30), proANP(31-67), and proANP(79-98) fragments. ProANP(1-30) and proANP(31-67) have roles in fluid and electrolyte homeostasis. The aim of the present study was to develop a plasma assay for proANP(1-30) and proANP(31-67) and to compare results in trained athletes and sedentary subjects.
  
  
  METHODS
  Two competitive enzyme immunoassays were established with affinity-purified sheep antiserum against synthetic ANP fragments. The immunoreactivity (ir) of proANP(1-30) and proANP(31-67) was measured in 10-microL plasma samples without extraction in a microwell-based assay. Plasma concentrations in sedentary male subjects (n = 22) and male endurance athletes (n = 14) were examined.
  
  
  RESULTS
  In the assay for ir-proANP(1-30) and ir-proANP(31-67), the concentrations at 95% B/B(0) were 4.7 and 14.2 pmol/L, respectively. Within-run CVs were 4-6% and 5-6%, and between-run CVs were 9% for both assays. Both assays were linear on dilution (y = 0.9945x - 0. 7291 and y = 1.0001x - 3.428), and the recoveries were 102-112% and 102-106%, respectively. In the sedentary and athletic groups, the ir-proANP(1-30) concentrations were similar: 318 +/- 38 pmol/L and 312 +/- 25 pmol/L (mean +/- SE), respectively, whereas the ir-proANP(31-67) was higher in the rowers (713 +/- 81 pmol/L) than in the sedentary subjects (387 +/- 71 pmol/L; P <0.005).
  
  
  CONCLUSIONS
  The proANP fragment assays are precise (CV <10%) and exhibit nearly quantitative recovery (102-112%). Only ir-proANP(31-67) responds to physical training.
authors.affiliation: Department of Medical Diagnostic Sciences and Special Therapy, University of Padua, Italy. depalo@ux1.unipd.it
authors.forename: E F
authors.initials: EF
authors.lastname: De Palo
authors.forename: W
authors.initials: W
authors.lastname: Woloszczuk
authors.forename: M
authors.initials: M
authors.lastname: Meneghetti
authors.forename: C B
authors.initials: CB
authors.lastname: De Palo
authors.forename: H B
authors.initials: HB
authors.lastname: Nielsen
authors.forename: N H
authors.initials: NH
authors.lastname: Secher
mesh_terms: D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood* / Q000737:chemistry; D001775:Blood Circulation; D003429:Cross Reactions; D006801:Humans; D007106:Immune Sera; D007124:Immunoenzyme Techniques; D008297:Male; D010446:Peptide Fragments / Q000097:blood* / Q000737:chemistry / Q000276:immunology; D011498:Protein Precursors / Q000097:blood* / Q000737:chemistry; D012680:Sensitivity and Specificity; D012756:Sheep; D013177:Sports
chemical_list: D007106:Immune Sera; D010446:Peptide Fragments; D011498:Protein Precursors; D009320:Atrial Natriuretic Factor